10th October
Current Perspectives in Haematological Malignancies
Manchester

Manchester Hall, 36 Bridge St, Manchester M3 3BT

PROGRAMME TOPICS:

CLL
Relapsed CLL: Have the new therapies completely replaced chemotherapy?

AML
Evolution in the management of AML

ALL
MRD and blinatumomab
MRD relevance pre and post-transplant

Workshop in Myeloma
Upfront treatments
Relapse in myeloma
Patient-based discussion

MDS
New treatments and iron chelation

Infectious Diseases in Haematology
Hepatitis & TB

Lymphoma MDT – Carousel of Cases
Adolescent TYA and chemotherapy – OEPA/COPDac versus ABVD
Improving RCHOP? Update on trials in progress
Combined modality treatment in early Hodgkin lymphoma
Refractory late Hodgkin lymphoma
Hodgkin lymphoma – H10 vs RAPID vs HD12/16
Chemo free in follicular lymphoma
Treating an 84 year old – assessment factors
How to get patients to CAR T cell therapy – what’s happening in your region?

Confirmed Speakers:
· Professor Graham Jackson, NCCC Newcastle
· Professor Gordon Cook Leeds Teaching Hospitals
· Dr Mike Dennis Christie Hospital, Manchester
· Dr George Follows Addenbrooke’s Hospital, Cambridge
· Professor Tim Illidge Christie Hospital, Manchester
· Professor Graham Jackson NCCC Newcastle
· Dr Jonathan Kell University Hospital of Wales, Cardiff
· Dr Tobias Menne NCCC Newcastle
· Dr Andrew McMillan Nottingham University Hospitals
· Dr Wendy Osborne NCCC Newcastle
· Dr Anne Parker Queen Elizabeth University Hospital, Glasgow
· Dr Steve Robinson University Hospitals Bristol

Registration Fees:

(inclusive of VAT @ 20%)

Consultants

Trainees / Nurses*

Standard Fee (until 25th September)

£72

£60

Late Fee (from 26th September)

£108

£108

* 20 free places available for Trainees & Nurses (allocated on a first-come, first-served basis – please email meetings@hartleytaylor.co.uk to check availability)

Hartley Taylor Medical Communications Ltd
Caledonian House | Tatton Street
Knutsford | Cheshire | WA16 6AG
Tel: ++44 (0)1565 621967